ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that the com ...

Oppenheimer has initiated coverage on Larimar Therapeutics, emphasizing its lead program Nomlabofusp as a transformative therapy for Friedreich's ataxia. With a price target of $26, the company plans ...

In June, Teva Pharmaceuticals Inc. TEVA reportedly sued Corcept Therapeutics ... Price Action: CORT stock is up 5.19% at $46.21 at the last check on Monday.

Corcept could be significantly undervalued based on long term potential growth and science-based innovation. Find out why ...

Testing volume at Modern Canna in Lakeland could as much as triple if Floridians vote to legalize the recreational ...

Briquilimab was well tolerated in the study. No SAEs or AEs grade 3 were reported. Furthermore, there were no reported AEs related to hair or skin color changes, hypersensitivity, or anemia. Mild ...

Prohibiting medical use of the substance colloquially known as “molly” and reinforcing its Schedule I classification, the early-August decision rejecting Lykos Therapeutics’ application for ...

In total, investors put $40.5 billion into startups across all stages in Q3. That’s a decline of 10% from the prior quarter ...

Perspective Therapeutics has done well to advance several radiotherapeutics to treat various types of cancers. Again, I think it was important to bring up VMT-01 for the targeting of patients with ...

Regular follow-up appointments allow for ongoing adjustments to the dietary ... recommendation (per research published in the Journal of Clinical Pharmacy and Therapeutics). A good way to know whether ...

The optimism for therapeutics is so much greater than even two or three ... Disinhibited behavior—doing things that are a bit off-color or out of character for that individual," Dr. Boeve explains.

Find out what Sophie Hahn, Kate Harrison and Adena Ishii have to say about public safety, housing and their big ideas for ...